Pretium Packaging LLC has acquired Starplex Scientific Inc, a Toronto-based maker of plastic containers and closures for the food, specialty beverage, household and industrial, sports nutrition, healthcare and beauty care industries.
Terms weren’t released for the deal, which will see Starplex retain its existing brand. The seller was Apotex Corp, a Canadian pharmaceutical company.
Pretium, a Chesterfield, Missouri-based maker of rigid plastic containers and closures, said the acquisition will support its growth objectives in the medical and consumer healthcare sectors.
Starplex is Pretium’s seventh add-on deal since the company was acquired in 2014 by U.S. mid-market private equity firm Genstar Capital.
Pretium Packaging acquires healthcare packaging, products company Starplex Scientific
Chesterfield, Mo., August 19, 2019—Pretium Packaging, a leading North American manufacturer of rigid plastic containers and closures, has acquired Starplex Scientific Inc., Toronto, Ontario, Canada from Apotex Corp.
The Starplex acquisition supports Pretium’s growth objectives in the medical and consumer healthcare market sectors.
Starplex Scientific has built highly-respected product lines including leak-resistant sterilized containers, biological sampling swabs and pharmaceutical grade containers and closures. Its products serve the clinical, laboratory and drug manufacturing markets in the United States and Canada.
Products are produced from ISO13485-certified operations in Toronto and Cleveland, Tennessee, with a combined 200,000–plus square feet of manufacturing space.
In keeping with Pretium’s ongoing acquisition philosophy, existing employees and the Starplex Scientific brand will be retained.
“The acquisition of Starplex Scientific is another example of Pretium merging independent, well-run companies with strong brand presence, a robust product line and complementary geographic locations into our existing family of companies. Starplex’s quality systems and medical device knowledge, will be welcome additions to our growing healthcare market segment.” said Paul Kayser, president and chief executive officer of Pretium.
David Golde, managing director at Genstar Capital, stated, “Genstar is pleased to be sponsoring Pretium’s acquisition of Starplex Scientific. The acquisition represents the seventh completed during Genstar’s ownership. Starplex has a well-respected brand and market presence in medical consumables and healthcare packaging, both of which represent key areas of continued investment and growth for Pretium.”
Pretium Packaging is a leading North American manufacturer of plastic containers and closures for the food, specialty beverage, household and industrial, sports nutrition, healthcare, and beauty care industries. Pretium manufactures well over two billion PET, PP and HDPE containers, jars and closures annually from its 19 locations across the United States and Canada for more than 900 customers. For more information: www.pretiumpkg.com.
About Starplex Scientific
Starplex Scientific manufacturers leak-resistant sample collectors and pharmaceutical/ nutraceutical bottles. The company’s products include specimen containers, transport vials, collectors, swab tips and shafts, O-ring containers, buckets and tissue cassettes. It serves the healthcare, environmental/industrial, veterinary and pharmaceutical/ nutraceutical sectors in North America. For more information: www.starplexscientific.com.
About Genstar Capital
Genstar Capital (www.gencap.com) is a leading private equity firm that has been actively investing in high quality companies for over 30 years. Based in San Francisco, Genstar works in partnership with its management teams and its network of strategic advisors to transform its portfolio companies into industry-leading businesses. Genstar currently has approximately $17 billion of assets under management and targets investments focused on targeted segments of the industrial technology, healthcare, software, and financial services industries.